Kane Biotech Secures $250,000 Insider Loan for Working Capital
Kane Biotech Inc. has accepted a $250,000 unsecured, non-interest-bearing loan from its Board Chair, Philip Renaud, to bolster working capital.

Kane Biotech Inc. has accepted a $250,000 unsecured, non-interest-bearing loan from its Board Chair, Philip Renaud, to bolster working capital.

Alcon has announced the over-the-counter approval of its Brytly eye drops, marking a strategic expansion in its product portfolio and market reach.

The Paris Motor Show kicks off with a record number of Chinese brands, intensifying competition with European carmakers. The EU also announced...

TD and BMO are under U.S. regulatory scrutiny for 'debanking' clients. Meanwhile, a Super El Niño threatens Canadian gas revenues, and immigration...

A Jersey politician has criticized the government's decision to end a free fruit trial in primary schools, arguing that cost-of-living pressures were...

The IMF has slightly upgraded its 2026 global growth forecast to 3.1%, attributing the revision to resilient advanced economies despite rising energy...

Brent crude oil futures have reached $110 per barrel for the first time since May, while U.S. WTI crude has climbed above...

Bank of America faces a $1.2 billion fine from the US Treasury for failing to detect and report over $5 billion in...

The average long-term U.S. mortgage rate remained at 7.40% this week, marking its highest level in nearly three years and concluding a...

Gold prices are registering modest gains during Friday's trading, building on a significant rebound from the previous session. Despite the uptick, prices...

DHL AG has raised its full-year 2026 EBIT outlook, citing strong Q3 performance, continued earnings momentum in its Express division, and a...

The Northwest Territories is advocating for a 'North of 60 Mineral Exploration Tax Credit' to attract investment and increase production in Canada's...